Repurposing of <scp>FDA</scp> ‐Approved Drugs to Disrupt Iron Uptake in <i>Mycobacterium abscessus</i> : Targeting Salicylate Synthase as a Novel Approach
- DOI
- 10.1111/cbdd.70162
- Published
- 2025-07-29
- Container
- Chemical Biology & Drug Design
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/cbdd.70162,
title = {Repurposing of
<scp>FDA</scp>
‐Approved Drugs to Disrupt Iron Uptake in
<i>Mycobacterium abscessus</i>
: Targeting Salicylate Synthase as a Novel Approach},
author = {Giovanni Stelitano and Christian Bettoni and Matteo Mori and Mario Cocorullo and Andrea Tresoldi and Fiorella Meneghetti and Stefania Villa and Laurent R. Chiarelli},
year = {2025},
journal = {Chemical Biology \& Drug Design},
doi = {10.1111/cbdd.70162},
url = {https://doi.org/10.1111/cbdd.70162}
}RIS
TY - JOUR
TI - Repurposing of
<scp>FDA</scp>
‐Approved Drugs to Disrupt Iron Uptake in
<i>Mycobacterium abscessus</i>
: Targeting Salicylate Synthase as a Novel Approach
AU - Giovanni Stelitano
AU - Christian Bettoni
AU - Matteo Mori
AU - Mario Cocorullo
AU - Andrea Tresoldi
AU - Fiorella Meneghetti
AU - Stefania Villa
AU - Laurent R. Chiarelli
PY - 2025
JO - Chemical Biology & Drug Design
DO - 10.1111/cbdd.70162
UR - https://doi.org/10.1111/cbdd.70162
ER - APA
Stelitano, G., Bettoni, C., Mori, M., Cocorullo, M., Tresoldi, A., Meneghetti, F., Villa, S., & Chiarelli, L. R. (2025). Repurposing of <scp>FDA</scp> ‐Approved Drugs to Disrupt Iron Uptake in <i>Mycobacterium abscessus</i> : Targeting Salicylate Synthase as a Novel Approach. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70162
Source records
- crossref · retrieved 2026-09-27T02:37:22.663Z